Pacylex Pharmaceuticals Selected as One of Sixteen Canadian Startup Companies to Present at Sweet Biopharma Day 2023

Pacylex Pharmaceuticals today announced it will be presenting at two exclusive life science startup events in Canada in April, spotlighting its emergence as one of the premier Canadian biotech startup companies. Pacylex is focused on innovative research and development and is a leader in the maturing Canadian biotech ecosystem.

A panel of pharmaceutical industry professionals selected Pacylex as one of only 16 Canadian startup companies to highlight at the annual Sweet Biopharma Day on April 12 in Mirabel, Québec. The following week, Pacylex will present at another invitation-only event, the Creative Destruction Labs (CDL)-Vancouver's Alumni Showcase on April 19.  Pacylex was part of the CDL’s Health cohort in 2020 that was cut short by the COVID-19 pandemic.

Read the full press release here.